Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

PHASE3CompletedINTERVENTIONAL
Enrollment

5,197

Participants

Timeline

Start Date

November 21, 2020

Primary Completion Date

August 16, 2022

Study Completion Date

December 8, 2023

Conditions
COVID-19
Interventions
DRUG

AZD7442

"* Single dose (× 2IM injections) of 300 mg of AZD7442 on parent study Day 1.~* Single dose (× 2IM injections) of 300 mg of AZD7442 on sub-study Day 1.~* Single dose (× 2IM injections) of 300 mg of AZD7442 on sub-study Day 183.~* Single dose (x 2IM injections) of 600mg of AZD7442 on sub-study Day 183 and Day 366"

DRUG

Placebo

Single dose (× 2IM injections) of saline placebo on parent study Day 1.

Trial Locations (89)

1000

Research Site, Brussels

3570

Research Site, Alken

5101

Research Site, Namur

6534

Research Site, Gozée

9230

Research Site, Wetteren

10461

Research Site, The Bronx

11385

Research Site, Ridgewood

11432

Research Site, Jamaica

21079

Research Site, Dijon

22304

Research Site, Alexandria

23320

Research Site, Chesapeake

27410

Research Site, Greensboro

28034

Research Site, Madrid

28040

Research Site, Madrid

28223

Research Site, Pozuelo de Alarcón

29485

Research Site, Summerville

29603

Research Site, Marbella (Málaga)

30060

Research Site, Marietta

30094

Research Site, Conyers

30328

Research Site, Atlanta

31904

Research Site, Columbus

32174

Research Site, Ormond Beach

33024

Research Site, Hollywood

33064

Research Site, Pompano Beach

33071

Research Site, Coral Springs

33125

Research Site, Miami

33313

Research Site, Lauderdale Lakes

33409

Research Site, West Palm Beach

33545

Research Site, Wesley Chapel

33756

Research Site, Clearwater

35215

Research Site, Birmingham

37044

Research Site, Tours

42055

Research Site, Saint-Etienne

43213

Research Site, Columbus

44093

Research Site, Nantes

46060

Research Site, Noblesville

47714

Research Site, Evansville

55404

Research Site, Minneapolis

55435

Research Site, Minneapolis

57701

Research Site, Rapid City

59037

Research Site, Lille

60429

Research Site, Hazel Crest

60607

Research Site, Chicago

62301

Research Site, Quincy

63003

Research Site, Clermont-Ferrand

63141

Research Site, St Louis

67205

Research Site, Wichita

67214

Research Site, Wichita

68134

Research Site, Omaha

72205

Research Site, Little Rock

73104

Research Site, Oklahoma City

75475

Research Site, Paris

75679

Research Site, Paris

77054

Research Site, Houston

77384

Research Site, Shenandoah

77479

Research Site, Sugar Land

78215

Research Site, San Antonio

78251

Research Site, San Antonio

78751

Research Site, Austin

79925

Research Site, El Paso

79935

Research Site, El Paso

84041

Research Site, Layton

85284

Research Site, Tempe

85925

Research Site, La Roche S/ Yon Cedex 9

87000

Research Site, Limoges

87109

Research Site, Albuquerque

89128

Research Site, Las Vegas

90703

Research Site, Cerritos

92394

Research Site, Victorville

92647

Research Site, Huntington Beach

92683

Research Site, Westminster

92844

Research Site, Garden Grove

93534

Research Site, Lancaster

93720

Research Site, Fresno

95350

Research Site, Modesto

96859

Research Site, Honolulu

98402

Research Site, Tacoma

06112

Research Site, Hartford

06762

Research Site, Middlebury

08036

Research Site, Barcelona

BH7 7DW

Research Site, Bournemouth

EN3 4GS

Research Site, Enfield

TR27 5DT

Research Site, Hayle

WC1N 3BG

Research Site, London

PR1 6YA

Research Site, Preston

OL11 4AU

Research Site, Rochdale

M6 8HD

Research Site, Salford

PL11 2TB

Research Site, Torpoint

WF1 5RH

Research Site, Wakefield

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

AstraZeneca

INDUSTRY